Peppermint Venture Partners Founded 1992
Founders Klaus Stoeckemann
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 8
Rounds per year 0.28
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Stages of investment
Early Stage Venture
Areas of investment
Biotechnology
Health Care
Lifestyle
Software
Telecommunications
Summary

In 2010 was created Peppermint Venture Partners, which is appeared as VC. The leading representative office of defined VC is situated in the Berlin. The fund was located in Europe if to be more exact in Germany.

The typical case for the fund is to invest in rounds with 4 participants. Despite the Peppermint Venture Partners, startups are often financed by High-Tech Gru00fcnderfonds, NRW.BANK, KfW. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, NRW.BANK, KfW. In the next rounds fund is usually obtained by High-Tech Gru00fcnderfonds, NRW.BANK, Meusinvest.

We can highlight the next thriving fund investment areas, such as Biopharma, Medical Device. Among the various public portfolio startups of the fund, we may underline Miracor Medical, Implandata Ophthalmic Products, Humedics Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has specific favorite in a number of founders of portfolio startups.

The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016. The common things for fund are deals in the range of 5 - 10 millions dollars.

The fund was created by Klaus Stoeckemann. We also calculated 3 valuable employees in our database.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
CryoTherapeutics
Biotechnology
Clinical Trials
Health Care
Medical
Therapeutic Devices
Therapeutics
Early Stage Venture
8M27 Jun 2019 Germany, Potsdam
Implandata Ophthalmic Products
Health Care
Medical
Medical Device
Wellness
Late Stage Venture
14 May 2018 Germany, Hanover
Miracor Medical
Health Care
Health Diagnostics
Medical
Medical Device
Personal Health
Late Stage Venture
29M04 Jan 2018 Belgium, Awans
Miracor Medical
Health Care
Health Diagnostics
Medical
Medical Device
Personal Health
Late Stage Venture
8M25 Oct 2016 Belgium, Awans
CryoTherapeutics
Biotechnology
Clinical Trials
Health Care
Medical
Therapeutic Devices
Therapeutics
Early Stage Venture
6M07 Jul 2016 Germany, Potsdam
Emperra
Health Care
Hospital
Medical
Early Stage Venture
3M04 Jan 2016 Germany, Potsdam
Biopharma
Biotechnology
Health Care
Venture - Series Unknown
5M30 Jul 2015 Germany, Cologne
Humedics
Biotechnology
Medical Device
Test and Measurement
Late Stage Venture
7M10 Nov 2014 Germany, Berlin
Implandata Ophthalmic Products
Health Care
Medical
Medical Device
Wellness
Early Stage Venture
3M27 Oct 2014 Germany, Hanover
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Peppermint Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: